Land: Schweiz
Sprache: Deutsch
Quelle: Swissmedic (Swiss Agency for Therapeutic Products)
cetirizini dihydrochloridum, pseudoephedrini hydrochloridum
UCB-Pharma SA
R06AE07
cetirizini dihydrochloridum, pseudoephedrini hydrochloridum
Retardtabletten
cetirizini dihydrochloridum 5 mg, pseudoephedrini hydrochloridum 120 mg, hypromellosum, lactosum monohydricum 43.23 mg, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 0.122 mg, pellicule: hypromellosum, E 171, macrogolum 400, pro compresso obducto.
B
Synthetika
Allergische Rhinitis
zugelassen
2003-09-12